HomeBOLD • NASDAQ
add
Boundless Bio Inc
Previous close
$4.19
Day range
$4.05 - $4.35
Year range
$3.60 - $15.24
Market cap
95.69M USD
Avg Volume
143.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 16.88M | 39.68% |
Net income | -15.43M | -31.67% |
Net profit margin | — | — |
Earnings per share | -12.27 | — |
EBITDA | -16.62M | -40.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 104.88M | 57.20% |
Total assets | 117.08M | — |
Total liabilities | 10.64M | — |
Total equity | 106.43M | — |
Shares outstanding | 22.25M | — |
Price to book | -0.04 | — |
Return on assets | -34.18% | — |
Return on capital | -36.59% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -15.43M | -31.67% |
Cash from operations | -15.78M | -30.49% |
Cash from investing | 18.14M | -18.18% |
Cash from financing | -924.00K | -3,080.65% |
Net change in cash | 1.44M | -85.78% |
Free cash flow | -10.92M | — |
About
Founded
2018
Website
Employees
72